|
Basic InformationMore InformationLatest NewsData Support Basing Health Decisions on Both Benefit, CostAbout One in Four Uninsured Could Be Excluded From ACACardiologist Calls for Action on Added SugarsCOPD May Be Over-Diagnosed Among UninsuredDigital Divide Exists With Physician EHR AdoptionDSM-4 Task Force Chairman Advises Caution With DSM-5Latest Edition of Psychiatry's 'Bible' Launched Amid ControversyMost Americans Say 'No' to Smoking in Their Homes, CarsCognitive Health Info From Doctors Found to Be Lacking'Nonsmoking' Hotel Rooms May Not Fully Protect GuestsUser Satisfaction With Electronic Health Records DownLook for New, Improved Sunscreen LabelsApplication for Health Coverage Has Been Simplified, ShortenedHospital Bills Can Vary Widely, Even in Same CitiesMoney Motivates Weight Loss -- One Step at a TimeFDA Proposes Tougher Warnings for Tanning BedsPotentially Toxic Metals Present in Lip CosmeticsPatients Most Annoyed by Long Waits, Unclear Test ResultsWhite House to Challenge Ruling on Unlimited Access to 'Morning-After' PillLipsticks, Glosses Contain Toxic Metals: ReportFDA Concerned Caffeinated Foods Could Harm ChildrenRenewed Efforts From AAFP to Repeal OTC Provision in ACAFDA Announces New Network to Focus Exclusively on PatientsPrescription Drug Take-Back Day Set for SaturdayHealth Insurance Shortfalls Hit Nearly Half of U.S. Adults: ReportAlmost Half of Americans Would Consider Donating Kidney to Stranger: PollPhysicians Less Empathetic in Talking to Heavy PatientsMost Americans Oppose Soda, Candy TaxesDiagnostic Errors Are the Leading Type of Malpractice ClaimAmerican Lung Association Stresses Clean Air Act BenefitsHospitalization OK for Psych Patients Can Take HoursU.S. Shortfall in Neurologists Expected to Get WorseUSPSTF: Primary Care Screening Can Help ID Suicide RiskU.S. Supreme Court Rejects Challenge to New Cigarette LabelingPatient-Centered Decision Making Ups Health OutcomesGuidelines Issued Relating to Online Medical ProfessionalismAlzheimer's Patients May Face Looming Shortage of NeurologistsClinical Trials Helped One Woman's Fight Against CancerSmoking Bans in Public Housing Could Save Dollars, Lives: CDCDoctors Order Fewer Lab Tests When They Know the CostDoctors' Insight Into Patients' Lives May Boost Care, Study FindsFDA Warns Against Sale of Sports Supplements in U.S.Most ED Docs, Nurses Doubtful About Suicide PreventabilityDoctors Urged to Refrain from Social Media Contacts With PatientsStrides Made in Preventing Cancer, But Challenges Remain: ReportDrug Company Reps Don't Tell Docs Enough About Side Effects: SurveyHospitals Work to Reduce Unnecessary Early BirthsMany Americans Skipping Meds to Save Money, CDC SaysFederal Judge Rules FDA Must Lift Restrictions on Plan BMental Health Care Lacking for Kids, Advocates Say Questions and AnswersLinksBook Reviews |
| |
When Prescription Drugs Go OTC, Ads Talk Less of Harms: Study
by By Jenifer GoodwinHealthDay Reporter
Updated: Sep 11th 2012
TUESDAY, Sept. 11 (HealthDay News) -- When prescription drugs become available over-the-counter, advertisements for the medications are far less likely to tell consumers about the potential harms and side effects, new research finds.
The reason for it, experts say, likely has to do with which federal agency regulates the marketing materials for each type of drug. The U.S. Food and Drug Administration (FDA) regulates ads for prescription drugs, while ads for over-the-counter drugs are regulated by the U.S. Federal Trade Commission (FTC).
The FTC has much less stringent standards than the FDA for what manufacturers have to reveal about products in their marketing materials, the researchers noted.
The FDA requires prescription drug advertising to provide consumers with a "fair balance" of risks and benefits -- for drug ads, that often means rattling off a lengthy list of potential side effects.
The FTC, on the other hand, holds drug advertisements to the same standards as other consumer products, requiring a "reasonable" standard of truthfulness.
The looser requirements mean that information about potential side effects and harm aren't included in most over-the-counter drug ads, said study author Dr. Jeremy Greene, an associate professor in the history of medicine department and the department of medicine at Johns Hopkins University.
"One of the FDA's guiding principles for regulating direct-to-consumer ads for prescription drugs is there needs to be a fair presentation of the risks and benefits," Greene explained. "The FTC has fewer requirements or specific regulations for how risks and benefits should be presented. The FTC is interested in making sure there are no fraudulent statements being made, and there is no active deception."
The findings are published in the Sept. 12 issue of the Journal of the American Medical Association.
Greene and his colleagues analyzed print and broadcast advertisements for four commonly used drugs that were heavily marketed to consumers as prescription drugs and then approved for sale over-the-counter.
The drugs included loratadine (brand name: Claritin, sold over-the-counter since 2002), omeprazole (brand name: Prilosec, went over-the-counter in 2004), orlistat (brand name: Alli, Xenical, sold over-the-counter since 2007), and cetirizine (brand name: Zyrtec, sold over-the-counter since 2008).
When the drugs were available only by prescription, 70 percent of the ads mentioned potential harms. After the drugs were available over-the-counter, only 11 percent did, the investigators found.
After drugs became available over-the-counter, only about half of print and broadcast advertisements mentioned a drug's generic name, compared to 94 percent of ads when drugs were prescription-only. Knowing a drug's generic name can help consumers make sure they're not taking more than one medication that has it as a component, risking overdose, Greene explained.
To give consumers the information they need to better understand risk, the FDA should be given authority to regulate marketing of over-the-counter drugs, or perhaps the FTC should adopt guidelines similar to what the FDA requires, according to Greene.
That said, few think even the FDA's "fair balance" guidelines are sufficient enough to really inform, he added.
Drug company advertising often includes a laundry list of potential side effects. That offers consumers little way to determine which risks they should pay the most attention to, or which risks should impact their decision-making about taking the drug, said Diane Pinakiewicz, president of the National Patient Safety Foundation.
"That is fulfilling the fair balance requirements, but the real purpose should be education of the consumer on the benefits and the risks of a drug in language people can understand, and fair balance doesn't do that effectively at all," Pinakiewicz said.
With consumers getting even less information about the risks of over-the-counter drugs, she suggests people consult with their physicians or their pharmacist about any medications they're taking.
Overdoses on acetaminophen (Tylenol) or ibuprofen (Advil) have become all too common, Greene added, highlighting that even the most commonplace drugs can have a downside.
"Once a drug becomes over-the-counter, it can still be quite dangerous and possibly fatal," Greene said.
More information
The Consumer Healthcare Products Association has more on over-the-counter drug safety.
This article: Copyright © 2012 HealthDay. All rights reserved. |